ProCE Banner Activity

Similarities and Differences of CLL/SLL Agents by Drug Class

Slideset Download
Download these expert-selected slides examining the MOAs and adverse event profiles of drugs treating chronic lymphocytic leukemia and small lymphocytic lymphoma.

Released: June 07, 2022

Expiration: June 06, 2023

No longer available for credit.

Share

Faculty

Asher Chanan-Khan

Asher Chanan-Khan, MD

Associate Professor of Oncology
Attending Physician
, Department of Medicine
Member, Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, New York

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

BeiGene

Janssen administered by Scientific Affairs

Pharmacyclics an AbbVie Company

Faculty Disclosure

Primary Author

Asher Chanan-Khan, MD

Associate Professor of Oncology
Attending Physician
, Department of Medicine
Member, Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, New York